Information sur le cancer / Types de cancer / Rein / Traitement / Récidive

Alberta Health Services. (2017, November). Renal Cell Carcinoma Clinical Practice Guideline GU-003. Extrait de: https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu003-renal-cell.pdf.

Drugs and Health Products, Health Canada. (2018, July 5). Regulatory Decision Summary: Opdivo. Extrait de: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00382.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer (Version 2.2019). Extrait de: https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf.

Reaume MN, Basappa NS, Wood L, et al. Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017. (2017). Canadian Urological Association Journal. 11(10):310-320. Extrait de: https://www.kidneycancercanada.ca/media/1173779/2017-management-of-advanced-kidney-cancer.pdf.